2021
DOI: 10.1002/smll.202004975
|View full text |Cite
|
Sign up to set email alerts
|

Nanomedicines for Endometriosis: Lessons Learned from Cancer Research

Abstract: Endometriosis is an incurable gynecological disease characterized by the abnormal growth of endometrium‐like tissue, characteristic of the uterine lining, outside of the uterine cavity. Millions of people with endometriosis suffer from pelvic pain and infertility. This review aims to discuss whether nanomedicines that are promising therapeutic approaches for various diseases have the potential to create a paradigm shift in endometriosis management. For the first time, the available reports and achievements in … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
55
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 43 publications
(58 citation statements)
references
References 201 publications
(307 reference statements)
2
55
0
1
Order By: Relevance
“…Endometriosis (EMs) represents a chronic, inflammatory gynecological condition characterized by the presence of the uterine lining outside the uterine cavity [ 1 ]. EMs can be anatomically divided into three sub-groups: superficial peritoneal endometriosis, deeply infiltrating endometriosis, and ovarian endometriosis (O-EMs) [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…Endometriosis (EMs) represents a chronic, inflammatory gynecological condition characterized by the presence of the uterine lining outside the uterine cavity [ 1 ]. EMs can be anatomically divided into three sub-groups: superficial peritoneal endometriosis, deeply infiltrating endometriosis, and ovarian endometriosis (O-EMs) [ 2 ].…”
Section: Introductionmentioning
confidence: 99%
“…One technology in its infancy for the treatment of endometriosis is the use of nanoparticles to aid in the imaging of, directly treating or delivering drugs to treat endometriosis ( 87 ). The key limitation for this emerging technology is that the etiology and pathogenesis of endometriosis are unknown ( 87 ). Despite this, investment in nanomedicines for endometriosis could substantially augment the capacity to diagnose and treat endometriosis.…”
Section: Evolving Possibilitiesmentioning
confidence: 99%
“…Despite this, investment in nanomedicines for endometriosis could substantially augment the capacity to diagnose and treat endometriosis. Nanoparticles have shown a capacity to accumulate in endometriotic lesions ( 87 ), which could improve the use of imaging technologies to diagnose endometriosis. This technology could also provide a method for targeting endometriotic lesions without the requirement of surgery.…”
Section: Evolving Possibilitiesmentioning
confidence: 99%
“…Several studies show that nanoparticles of different core composition (Au, Cd, polymers, lipids, etc. ), size range (10-150 nm), and surface charge (+30-−20 mV) accumulate in endometriotic tissue [37]. The AgNPs that we used here share some features (size ~100 nm, surface PEGylation, and negative Z-potential) with clinically used…”
Section: Pl1-targeted Nanoparticles Internalize In 12z and Hesc Cellsmentioning
confidence: 99%